The Nanōmix Story

A Legacy of Innovation.

Nanōmix was founded in 2000 by UC Berkeley professors and award-winning physicists at Lawrence Berkeley National Laboratory, Marvin L. Cohen and Alex Zettl.  The first phase of development delivered a proprietary, scalable carbon nanotube biosensor technology.   In 2009, Nanōmix turned its focus to bringing the biosensor technology to the Point of Care in vitro diagnostics market.

Today, Nanōmix is poised to become the premier provider of analytical detection devices for the next generation of rapid point of care diagnostics in the projected $7 billion global POC market (2018).

quality healthcare availability